OTCMKTS:TRXDW TransEnterix (TRXDW) Stock Price, News & Analysis $0.15 0.00 (0.00%) As of 09/24/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About TransEnterix Stock (OTCMKTS:TRXDW) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TransEnterix alerts:Sign Up Key Stats Today's Range$0.15▼$0.1550-Day Range$0.15▼$0.1552-Week Range$0.12▼$0.18VolumeN/AAverage Volume8,250 shsMarket Capitalization$21.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview TransEnterix, Inc. was a medical device company focused on developing and commercializing minimally invasive surgical technologies. The company’s principal product was the Senhance Surgical System, a digitally enabled laparoscopic platform designed to assist surgeons with visualization, instrument control, ergonomics and precision during minimally invasive procedures. The Senhance system was developed for use across a range of laparoscopic specialties, including general surgery, gynecology and urology. TransEnterix pursued regulatory clearances and commercial opportunities in the United States and international markets, including Europe and Japan, and supported hospitals with related instruments, accessories and digital surgical technology. In 2020, TransEnterix changed its corporate name to Asensus Surgical, Inc. to reflect its broader focus on digital surgery and the Senhance platform. The company was led by Todd M. Pope during much of its TransEnterix period, followed by Anthony Fernando as president and chief executive officer of Asensus Surgical. TransEnterix is therefore primarily associated with the company’s historical operations and the development of technology later marketed under the Asensus Surgical name.AI Generated. May Contain Errors. Read More Receive TRXDW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TransEnterix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRXDW Stock News HeadlinesLife Science Partners L P Synergy's Net WorthFebruary 9, 2024 | benzinga.comAsensus Surgical Inc (ASXC)January 30, 2024 | investing.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.September 25 at 1:00 AM | Banyan Hill Publishing (Ad)TransEnterix, Inc. (TRXDW)January 20, 2024 | ca.finance.yahoo.comSurgical Robots Global Market Report 2023June 13, 2023 | finance.yahoo.comAsensus Surgical (NYSEMKT: ASXC)May 27, 2023 | fool.comLiberia - Two Ex-Soldiers Claim Massaquoi Was At Waterside, Ordered Killings, RapesFebruary 26, 2023 | msn.comAsensus Surgical, Inc. To Present at The LD Micro Main Event XV - StreetInsider.comOctober 18, 2022 | streetinsider.comSee More Headlines TRXDW Stock Analysis - Frequently Asked Questions How have TRXDW shares performed this year? TransEnterix's stock was trading at $0.15 at the beginning of the year. Since then, TRXDW stock has increased by 0.0% and is now trading at $0.15. How were TransEnterix's earnings last quarter? TransEnterix, Inc. (OTCMKTS:TRXDW) announced its quarterly earnings results on Thursday, November, 5th. The medical instruments supplier reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.11. The medical instruments supplier earned $0.81 million during the quarter, compared to analyst estimates of $0.73 million. TransEnterix had a negative trailing twelve-month return on equity of 83.74% and a negative net margin of 2,149.15%. How do I buy shares of TransEnterix? Shares of TRXDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/05/2020Today9/25/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:TRXDW CIK876378 Webasensus.com Phone+1-919-7658400FaxN/AEmployees170Year Founded2006Profitability EPS (Trailing Twelve Months)($4.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$154.20 million Net Margins-2,149.15% Pretax MarginN/A Return on Equity-83.74% Return on Assets-64.94% Debt Debt-to-Equity Ratio0.04 Current Ratio3.24 Quick Ratio2.30 Sales & Book Value Annual Sales$8.53 million Price / Sales2.51 Cash Flow$0.11 per share Price / Cash Flow1.40 Book Value$2.68 per share Price / Book0.06Miscellaneous Outstanding Shares142,777,000Free FloatN/AMarket Cap$21.42 million OptionableNot Optionable Beta2.56 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:TRXDW) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransEnterix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransEnterix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.